ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Freedland on Treating Early-Stage Prostate Cancer

Stephen J. Freedland, MD
Published: Wednesday, Oct 31, 2012

Stephen J. Freedland, MD, Associate Professor of Surgery, Associate Professor in Pathology, Duke University School of Medicine, discusses the complications faced when treating men with early-stage prostate cancer.

Freedland notes that in the past few years there have been multiple new agents approved for advanced prostate cancer. Overall, the treatment choice for early-stage prostate cancer has remained hormonal therapy and likely will not change in the next 5 years, Freedland believes.

When administering androgen-deprivation therapy there are multiple expected adverse events, such as bone loss, cholesterol issues, and insulin intolerance. Despite the occurrence of these events, not every patient develops a bone fracture or a heart attack and proper preventive measures should be addressed with patients.

As a way to reduce the expected consequences of treating prostate cancer, Freedland stresses that physicians should promote the importance of healthy living and exercise.

Stephen J. Freedland, MD, Associate Professor of Surgery, Associate Professor in Pathology, Duke University School of Medicine, discusses the complications faced when treating men with early-stage prostate cancer.

Freedland notes that in the past few years there have been multiple new agents approved for advanced prostate cancer. Overall, the treatment choice for early-stage prostate cancer has remained hormonal therapy and likely will not change in the next 5 years, Freedland believes.

When administering androgen-deprivation therapy there are multiple expected adverse events, such as bone loss, cholesterol issues, and insulin intolerance. Despite the occurrence of these events, not every patient develops a bone fracture or a heart attack and proper preventive measures should be addressed with patients.

As a way to reduce the expected consequences of treating prostate cancer, Freedland stresses that physicians should promote the importance of healthy living and exercise.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x